The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 12, 2017
Filed:
Dec. 05, 2013
Applicant:
Strategia Therapeutics, Inc., Boston, MA (US);
Inventors:
Akinori Hishiya, Belmont, MA (US);
Keizo Koya, Chestnut Hill, MA (US);
Luca Rastelli, Norwell, MA (US);
Assignee:
SOLA Biosciences, LLC, Boston, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
A01B 9/00 (2006.01); C07K 14/31 (2006.01); C12P 21/02 (2006.01); C07K 14/54 (2006.01); C07K 14/315 (2006.01); C07K 14/47 (2006.01); C07K 14/715 (2006.01); C07K 14/755 (2006.01); C07K 14/81 (2006.01); C07K 16/22 (2006.01); C07K 16/24 (2006.01); C12N 9/64 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12P 21/02 (2013.01); C07K 14/31 (2013.01); C07K 14/315 (2013.01); C07K 14/47 (2013.01); C07K 14/5437 (2013.01); C07K 14/7155 (2013.01); C07K 14/755 (2013.01); C07K 14/8125 (2013.01); C07K 16/22 (2013.01); C07K 16/241 (2013.01); C07K 16/244 (2013.01); C12N 9/644 (2013.01); C12N 9/6437 (2013.01); A61K 48/00 (2013.01); C07K 2317/14 (2013.01); C07K 2319/00 (2013.01); C07K 2319/30 (2013.01); C07K 2319/35 (2013.01); C07K 2319/43 (2013.01); C07K 2319/70 (2013.01); C07K 2319/705 (2013.01);
Abstract
Fusion proteins comprising a protein expression enhancing polypeptide linked to a target protein binding domain and nucleic acid molecules encoding such fusion proteins are described for use in enhancing expression and/or location of a targeted protein of interest, for restoring lost functions in cells, and for treating disease. Additional fusion proteins comprising a target protein of interest modified with a fusion partner comprising a protein expression enhancing polypeptide are also disclosed.